| Product: | Hydantoin-4,5-13C2,1-15N | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | CN10663 | ||||||||
| Synonyms: | 2,4-Imidazolidinedione-4,5-13C2,1-15N; Imidazole-2,4(3H,5H)-dione-4,5-13C2,1-15N; Glycolylurea-4,5-13C2,1-15N; NSC 9226-4,5-13C2,1-15N | ||||||||
| Pricing: |
| ||||||||
| Formula: | C13C2H4N15NO2 | ||||||||
| Enrichment: | 98%:13C2, 98%:15N | ||||||||
| Molecular Weight: | 103.05 | ||||||||
| Structure: | ![]() | ||||||||
| Category: | Hydantoins and Derivatives | ||||||||
| Literature References: | Hanson, J.W., Myrianthopoulos, N.C., Harvey, M.A.S., Smith, D.W., Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. The Journal of Pediatrics, 1976, 89(4):662-668. | ||||||||
| MSDS: | Click here. | ||||||||
| Applications: | A labeled oxidized derivative of imidazolidine. Used as anticonvulsants. Used in the synthesis of amino acids. |
Medica Lisotopes我们的专家将根据您的规格和项目需要准备您的标记和未标记标准的合成,中间体的合成,代谢物合成/表征,代谢物合成/表征等化合物。



